Cipla partners with MSN Laboratories for marketing, distribution of generic Xeloda
Capecitabine tablets are indicated as a single agent for adjuvant treatment in patients with Dukes C colon cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Multipurpose stalls at railways stations sell generic low-cost medicine
In a written reply in Lok Sabha, Minister of State for Railways, Rajen Gohain said at present, three chemist stalls are…
Hester Biosciences Q1FY19 results: Sales up by 32%, profitability up by 57%
The main drivers for the improvement were reduction in the costs of goods sold and better inventory management
AstraZeneca receives marketing permission for Osimertinib to treat non-small cell lung cancer in…
Osimertinib (TagrissoTM) will be used as 1st line treatment for NSCLC offering potential new standard of care
ACG Inspection partners with Verinetics to further strengthen fight against falsified medicines
With this partnership, ACG Inspections is looking to implement an add-on security layer to provide Multi-Factor authentication to…
Novo Nordisk Pharmatech in agreement with Signet Chemical Corporation
The agreement will lead to the distribution of pharmaceutical range of quaternary ammonium compounds to the healthcare industry in…
Fix DAVA portal, says industry to DGFT
Faced with delays at ports and possible product recalls, industry hopes the DGFT will fix the issues with the DAVA portal as well…
Opportunity for biotech firms to pursue drug candidates targeting metabolic disorders
The GlobalData report found that big pharma companies lag behind small bio-techs in R&D efforts
Consulate General of Canada, PHARMEXCIL, Trade & Invest British Columbia host roadshow in…
The day-long session in Mumbai consisted of presentations from top Canadian pharmaceutical companies